JULY 2025

Upcoming Events & Opportunities

GISCi 2025: Advancing Risk-Based Approaches in Cancer Screening

📍Turin, 2–3 October 2025

The GISCi National Conference (Italian Group for Cervical Cancer Screening) will take place in Turin on 2 and 3 October 2025. The scientific program will address key challenges and innovations in cancer screening programs, with particular focus on new technological tools, emerging evidence, and the evolution of European recommendations.

Among the scheduled presentations, Paolo Giorgi Rossi will deliver an in-depth talk on risk-stratified screening, developed within the framework of the EUCanScreen Joint Action. His contribution will be part of the ONS–FASO–GISCi joint workshop on 2 October and will provide an update on the current state of the art in Europe and its implications for national screening programs.

The conference will also explore key topics shaping the future of screening, such as the integration of artificial intelligence, self-sampling, HPV genotyping, and the definition of new risk thresholds. Considerable attention will be given to organizational aspects, data governance, and the evaluation of the impact of implemented innovations.

This event offers a valuable opportunity for dialogue among experts, policymakers, and professionals involved in screening programs, with the aim of promoting more effective, sustainable, and personalized approaches.

📄Full program available here: GISCi 2025 Conference – PDF

Subscribe to our newsletter to get news and updates.

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959